Skip to content
★ Sign in to follow
CR

Christopher R. Loose

Directeur Scientifique
Total declarations
71
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (63 ops.)
€3.9M

Latest filing published 31 Jul 2023 for Frequency Therapeutics, Inc., €663.

Filing timeline

BuySale
Christopher R. Loose

Insider track record

Disclosed buys
0
Disclosed sells
63

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Christopher R. Loose: trading record in brief

Christopher R. Loose, listed as senior executive, appears in our data through filings on Korro Bio, Inc. shares, published by SEC (Form 4). In total, 71 filings cover trades dated from 7 October 2019 to 28 July 2023.

On the market, this insider has only sold: 63 sales, €3.9M in total. Other entries cover 7 option exercises. In 2023 alone, the filings show no purchases and 20 sales.

On 31 July 2023 came the latest disclosure, an open-market sale for €563 in Korro Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Christopher R. Loose

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations